Online Seminar on Crystallization Scale-up From METTLER TOLEDO

06:00 EST 28 Feb 2017 | PR Web

Featuring presenters from Merck, GlaxoSmithKline and APC Ltd, this free online event on 4/27/17 is for scientists and engineers interested in crystallization scale-up.

(PRWEB) February 28, 2017

METTLER TOLEDO has announced an online seminar focusing on an industrial perspective of successful techniques to develop a scalable crystallization process – Crystallization Scale-up: An Industry Perspective.

This crystallization online seminar is being held on Thursday, April 27, 2017 at 9:00 AM EDT/2:00 PM GMT. Each presentation will be followed by a live question-and-answer session with the speaker:

  • “Studies on a Pharmaceutical Drug Substance Crystallization with Floating Crystals”

Jorge Calderon de Anda, GlaxoSmithKline, Stevenage, UK

  • “Utilizing a Novel Wet Milling Crystallization Technique to Control Particle Size at Scale”

Dan Minkler, Merck, Rahway, NJ

  • “Crystallization Process Design to Ensure Successful Scale-up”

Damian Duffy PhD, APC Ltd, Dublin, Ireland

This event is for chemists and chemical engineers interested in crystallization scale-up in the chemical, pharmaceutical and consumer products industries as well as academia.

METTLER TOLEDO provides Process Analytical Technology (PAT), automated synthesis reactors, and in situ sampling. In situ FTIR spectroscopy and automated sampling provides continuous analysis of reactions. Inline particle analysis enables crystallization development with continuous particle size measurements. Automated reactors and reaction calorimetry provides process knowledge to identify and eliminate scale-up and safety incidents.

For the original version on PRWeb visit:


More From BioPortfolio on "Online Seminar on Crystallization Scale-up From METTLER TOLEDO"

Quick Search


Relevant Topics

Merck and Co
Merck & Co is the 7th largest pharmaceutical company in the world based on annual sales, which reached $25,236m in 2009. They have developed 14 vaccines and over 40 prescription products in the major therapeutic areas of cardiovascular disease, respi...

GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...